Alkermes (ALKS) Goodwill (2011 - 2026)

Alkermes (ALKS) posted quarterly Goodwill of $511.2 million for Q2 2026, down 14.22% quarter-over-quarter from $596.0 million in Q1 2026.

Alkermes (ALKS) Goodwill (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Goodwill for 16 consecutive years, with $511.2 million the latest figure, recorded in Q2 2026.

In Q2 2026, Goodwill changed N/A year-over-year to $511.2 million; the TTM figure through Jun 2026 stood at $511.2 million (changed N/A YoY), while the FY2025 annual figure was $83.0 million, changed 0.0% from the prior year.
Goodwill declined to $511.2 million in Q2 2026 per ALKS's latest filing, from $596.0 million in the prior quarter.
Across five years, Goodwill topped out at $596.0 million in Q1 2026 and bottomed at $83.0 million in Q4 2022.
Historically, Goodwill has averaged $149.7 million across 5 years, with a median of $92.9 million in 2022.
On a YoY basis, Goodwill climbed as much as 0.0% in 2022 and fell as far as 10.6% in 2022.
Alkermes' Goodwill stood at $83.0 million in 2022, then changed by 0.0% to $83.0 million in 2023, then changed by 0.0% to $83.0 million in 2024, then changed by 0.0% to $83.0 million in 2025, then surged by 515.76% to $511.2 million in 2026.
Business Quant data shows ALKS's Goodwill at $511.2 million in Q2 2026, $596.0 million in Q1 2026, and $83.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.19 Bn	19.53 Bn	683.80 Mn
6	Viatris	18.68 Bn	17.79 Bn	1.46 Bn
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Alkermes	8.12 Bn	7.46 Bn	397.90 Mn

Download Data